INTRODUCTION
Huanglongbing (HLB) is a serious disease of citrus and the major threat to citriculture worldwide. In the United States, HLB is associated with a Gram-negative, phloem-limited alphaproteobacterium, “
Candidatus Liberibacter asiaticus,” with several different strains of “
Ca. Liberibacter asiaticus” reported in association with citrus (
1–3). This bacterium is spread by insect psyllid vectors; the psyllid vector in the United States is the Asian citrus psyllid (ACP)
Diaphorina citri. Both the vector and the bacterium are invasive species in the United States. Symptoms of the disease include leaf chlorosis, blotchy mottle, limb dieback, root loss, phloem plugging, and overall sieve element collapse (
4,
5). Diseased trees produce small, bitter, hard, unevenly colored, and misshapen fruit. These fruits are unmarketable for juicing because the disease results in acidic, salty, and off-flavor juice. In addition to the unpalatable flavor, fruit borne of trees with severe HLB symptoms exhibit severe morphological distortions and seed discoloration, rendering them unsuitable for fresh-market sale (
6,
7). Infected trees decline rapidly and die within a few years of becoming infected, and HLB can spread throughout an orchard in a short period of time, especially when environmental conditions are favorable or mitigation measures are not applied (
8). All commercial citrus varieties are susceptible to HLB (
9,
10). Current management of HLB relies heavily on vector control via insecticide applications, and the development of alternative effective management strategies is ongoing (
11,
12). Section 18 emergency registration was approved in Florida for the use of the antibiotics streptomycin sulfate and oxytetracycline hydrochloride in citrus, and the studies regarding the efficacy of these antibiotics against HLB are ongoing (
11–13), with a recent study indicating that spray applications of oxytetracycline are ineffective at mitigating HLB (
14).
A diverse community of microorganisms is associated with plants, collectively referred to as a plant’s microbiome, and includes the collection of microbes associated with the rhizosphere (the soil-root interface), the phyllosphere (epiphytic, aerial surfaces), and the endosphere (internal tissues) (
15). Spatial and environmental factors as well as host immunity and microbe-microbe interactions can shape the microbiome community structure in these plant compartments (
16–19). Moreover, under disease conditions, microbial pathogens directly or indirectly interact with the host microbiome as well as the host itself. Because of the HLB epidemic and the lack of long-term sustainable effective control measures, there is an increased focus on the citrus microbiome and how it relates to the HLB disease phenotype that encompasses the entirety of the citrus microbial community and its associated chemistries (
20–22). High-throughput sequencing (HTS) technologies have significantly increased our knowledge regarding the members of plant-associated microbiomes, including those of citrus. However, besides pathogens and some well-studied symbionts, the vast majority of the functions of the plant microbiome are unknown, colloquially referred to as microbial “dark matter” (
23). Their intimate host associations suggest that these microbes may possess enormous untapped potential for promoting plant health, but the inherent complexity of these communities and their associated chemistries complicate efforts to decipher their respective contributions (
24,
25).
The next frontier in microbiome research is to move beyond microbial community profiling to define specific microbial contributions to phenotypes, such as plant health and disease outcomes (
26). These efforts are expedited by coupling big data sets derived from HTS technologies with reductionist experiments using microbial isolates in singlet or consortia that are derived from a given microbiome. Thus, establishing and maintaining culture collections alongside cognate culture-independent HTS data sets is a key component of unraveling the complexity of microbial functions within a host’s microbiome. HTS technologies in plant microbiomes have also enabled the field of microbial biocontrol to shift from single-agent control studies toward holistic, community-based investigations on the comprehensive microbiome of a given system (
27). However, the market for biocontrol agents or microbially derived natural product-based disease control applications is still heavily rooted in culture-dependent studies, because the development of microbe-derived formulations for commercial purposes requires culturable isolates that can be broadened to scaled-up fermentations. Thus, the integration of culture collections with culture-independent microbiome data sets is particularly relevant to the field of biocontrol and natural product-based disease control research.
Enduring biological control requires microbes that are adapted to changing host disease states as part of an integrated management strategy. The most successful biocontrol agents are those tailored to their target environment and that are capable of thriving across healthy and diseased host states (
28).
Rhizobium rhizogenes K84 (
29) is a model integrated biocontrol agent and used, along with the derived strain
Rhizobium rhizogenes K1026 (
30), to combat infection of
Agrobacterium tumefaciens in the rhizosphere of susceptible plants (
31). This biocontrol agent was isolated from
A. tumefaciens-infested rhizospheres where these two microbes evolved to compete with one another through an elegant interaction mechanism mediated by the antibiotic agrocin 84, allowing
R. rhizogenes to specifically inhibit virulent
A. tumefaciens strains carrying specific Ti plasmids (
32). A seemingly logical starting point for biocontrol bioprospecting efforts from within a host’s microbiome would focus on healthy or asymptomatic hosts. However, utilizing the success of
R. rhizogenes K84 and K1026 as a paradigm for the development of an effective biocontrol agent, it has been proposed that bioprospecting for biocontrol candidates should also include the microbiota from symptomatic hosts (
33,
34). A study in tomato also indicated that a pathogen-prevalent environment was a good source for isolating biocontrol agents for the vascular bacterial pathogen of solanaceous plants,
Ralstonia solanacearum (
35). These conditions select for candidate biocontrol agents capable of sustaining themselves within the parameters of the diseased plant environment. Moreover, these microorganisms interface with the pathogen either directly or indirectly and are potentially under selective pressure to engage in competitive interactions with the pathogen.
The collective aims of this work were to map the spatial anatomy of the citrus microbiome in different tissue niches of the tree (leaves, stems, and roots) and to mine those same niches for culturable microbiota to build a repository of citrus-associated microorganisms that dwell in the HLB disease environment and screen this repository for potential anti-“
Ca. Liberibacter asiaticus” bioinoculants. To accomplish this, we utilized a high-throughput culturing and taxonomic identification pipeline that allows for the rapid identification of large cohorts of culturable microbiota based on bulk-culturing techniques augmented with amplicon-based HTS technologies that alleviated the initial need for laborious subculturing into pure culture. We then isolated a subset of these microbial cohorts into pure culture to create a repository of axenic citrus microbial isolates. Operating under the premise that members of the citrus microbiome could be developed into HLB suppressors, we tested the hypothesis that members of the citrus microbiota can compete with “
Candidatus Liberibacter asiaticus” through antibiosis. Efforts to culture the “
Candidatus Liberibacter asiaticus” bacterium are ongoing and remain a large focus of the research community working on the HLB pathosystem (
36). However, the bacterium remains unculturable. Thus, “
Ca. Liberibacter asiaticus” is not amenable to manipulation
in vitro, which poses severe limitations on developing bioassays to screen compounds that target “
Ca. Liberibacter asiaticus” directly. Because of this, we turned to
L. crescens, the only cultivable species belonging to the
Liberibacter genus (
37).
L. crescens has also been detected in citrus, and several studies have established it as a suitable
in vitro model organism for “
Ca. Liberibacter asiaticus” (
38,
39). We integrated a robust
in vitro agar diffusion inhibition bioassay into our culturable microbiome pipeline that utilizes
L. crescens as a target to identify citrus-associated bacteria and fungi that produce metabolites that inhibit its growth. This
in vitro screening pipeline was validated by isolating natural products cladosporols A, C, and D with antimicrobial activity from the
L. crescens-antagonistic fungus
C. cladosporioides, thereby providing foundational data for the development of native citrus microbiome-derived therapeutic methods with potential application in HLB management practices and possibly other plant pathosystems as well.
DISCUSSION
Specific members or consortia of plant microbiomes can provide protection against plant pathogens through a variety of mechanisms ranging from niche displacement, production of antimicrobial compounds, and activation of induced systemic resistance (
46–52). Reductionist experiments facilitate mechanistic studies to elucidate the underlying biology of a system, rendering culture collections an important translational research tool to bridge big HTS data sets with biologically relevant activities. These resources enable critical inquiries into specific microbial interactions, such as linking functional phenotypes like pathogen suppression to specific microbiome constituents and their respective bioactive chemistries (
53). For this study, we designed a pipeline that allowed us to assign taxonomy to bulk cultures obtained from citrus tissues. This conveniently expedited taxonomic assignments by initially bypassing the need to isolate into pure culture. Moreover, our methodology was derived out of necessity to adapt to the regulatory logistics of working with “
Ca. Liberibacter asiaticus”-infected citrus tissues in California. HLB has only recently been confirmed in California (2012), and prior to that, the state was considered to be HLB free (
54). “
Ca. Liberibacter asiaticus” is a quarantine pathogen for the state of California, and as such, scientists in California are not permitted to import citrus tissues containing live “
Ca. Liberibacter asiaticus.” Tissue sampling and bulk culturing were performed in Florida, where bulk cultures were archived and stored temporarily. In California, HTS libraries were constructed, sequenced, and analyzed using DNA isolated from the bulk cultures. Once taxonomy was assigned to the microorganisms archived in Florida and confirmed to contain no known pathogens of citrus, federal importation permits were obtained, and the bulk cultures were imported to California, where isolation to pure culture was initiated. Inherent to any culturing process, the standardized growth media and conditions utilized in this study imposed a bottleneck on isolates derived from citrus tissue and significantly reduced bacterial and fungal species richness compared to that in the
in planta microbiome. Regardless, the citrus culture repository successfully captured many high-abundance bacterial and fungal taxa that were identified in the culture-independent data set, representing a higher-than-expected proportion of taxa observed
in planta across tissue types. Our citrus microbial collection includes metadata and barcode sequence for each microbial isolate (
20), and as we develop the repository, we expand our collection sites to include other geographic regions, such as California, where HLB is just beginning to manifest, along with a broader repertoire of culture conditions to better capture native microbial richness and diversity measures.
The culture repository of individual bacterial isolates is enriched in the genera
Bacillus and
Pantoea (
Table 1). These were also identified as core members of the citrus rhizosphere microbiome from citrus trees collected worldwide (
21). The commonalities we found among the dominant genera in the culture-independent leaf bacteriome with other citrus leaf bacteriome studies include
Methylobacterium and
Hymenobacter spp. (
55).
Pantoea,
Bacillus, and
Paenibacillus were identified as dominant root-associated genera (
21,
56,
57), and we also found these to be dominant genera in the leaf and stem tissue compartments in both our bulk culture-dependent and culture-independent works. To the best of our knowledge, only one other citrus microbiome study has reported on the mycobiome of citrus plants, where
Fusarium,
Exophiala, and
Colletotrichum were dominant fungal genera in the rhizosphere of citrus collected globally (
21). We also found these to be dominant fungal genera in our study. Several bacteria isolated from the rhizosphere of citrus in an HLB-impacted region in Florida were inhibitory against two bacteria,
Agrobacterium tumefaciens and
Sinorhizobium meliloti, which are phylogenetically related to “
Ca. Liberibacter asiaticus” (
58). The inhibitory isolates included those of
Burkholderia metallica,
Burkholderia territorii,
Pseudomonas granadensis,
Pseudomonas geniculata,
Rhodococcus jialingiae, and
Bacillus pumilus (
58). We did not recover these bacteria in our culture collection, likely due to the different medium types and culture conditions utilized in the Riera et al. study (
58), as well as potential differences in the microbiomes of different geographic regions and citrus cultivars with those in our study.
Many microbial natural products have been identified, purified, and developed into antimicrobials, with prototypical examples of naturally derived antibiotics being penicillin produced by Penicillium spp. and streptomycin produced by streptomycetes. Specific to the HLB pathosystem, the derived antimicrobial natural products streptomycin sulfate (FireWall 50WP; AgroSource, Inc.) and oxytetracycline hydrochloride (FireLine 17WP; AgroSource, Inc.) are being applied as spray applications to trees in Florida under Section 18 emergency registration in efforts to decrease pathogen titer and HLB severity. Microbial natural products can also serve as important starting points for bioactive drug discovery and synthesis pipelines.
The
L. crescens agar diffusion assay provides an efficient platform to prescreen microbes, crude supernatant extracts, fractionated natural product extracts, and purified natural product compounds
in vitro without the laborious and resource-intensive
in planta or insect studies currently necessary for screening compounds against “
Ca. Liberibacter asiaticus” growth. Although there are limitations inherent to using a surrogate bacterium, this work establishes a reservoir of candidate natural products and microbes for use in future
in vitro pipelines once culture methodology is sufficiently refined and “
Ca. Liberibacter asiaticus” sheds it “
Candidatus” status to be designated
Liberibacter asiaticus (
36). To initiate our work on anti-
L. crescens natural product purification from citrus-associated microbes, we focused our efforts on the
L. crescens-inhibitory fungus
C. cladosporioides. Cladosporium spp. are often identified as members of plant microbiomes and can promote plant health by directly antagonizing pathogens through the production of antimicrobial compounds or by producing plant growth-promoting compounds (
59,
60).
Bioassay-guided fractionation of the crude extract of
C. cladosporioides using the
L. crescens inhibition assay yielded cladosporols A (compound 1), C (compound 2), and D (compound 3) as the major bioactive compounds. Compound 1 was originally isolated from
C. cladosporioides and identified as a β-glucan biosynthesis inhibitor (
61). Compounds 2 and 3 and two other cladosporols (including compound 1) were isolated from
Cladosporium tenuissimum in an investigation of the biocontrol mechanisms of this hyperparasite of the rust fungus
Uromyces appendiculatus (
44). The stereochemical configurations of compound 2 and, by inference, compounds 1 and 3, were revised in 2017, and each was shown to have modest antibacterial activity against the bacteria
Escherichia coli,
Micrococcus luteus,
Vibrio harveyi (
62), and methicillin-resistant
Staphylococcus aureus (MRSA) (
45). Compound 1 has also attracted considerable interest as a peroxisome proliferator-activated receptor γ (PPARγ)-mediated inhibitor of cancer cell proliferation (see reference
63 and references therein). In this study, compounds 1 to 3 all displayed inhibitory activity against
L. crescens in a dose-dependent fashion, with slightly higher inhibition by compound 2.
We also identified other
L. crescens-inhibitory fungi and bacteria using our pipeline. Among the fungi screened, an isolate of
E. nigrum secreted compounds that robustly inhibited
L. crescens. The
Epicoccum genus includes many known plant endophytes and has been noted for its profuse secondary metabolite repertoire (
64).
E. nigrum is also an effective biocontrol agent in several plant systems (
65). Most notably, this fungus reduced symptom severity in periwinkle plants inoculated with the phloem-dwelling “
Candidatus Phytoplasma mali,” indicating that it interacts directly or indirectly with the phloem and thus may have some promise in combating “
Ca. Liberibacter asiaticus” in the phloem of citrus (
66). Interestingly, the genus is abundant in the citrus packing house environment (
64,
67). Among the bacteria screened from our cultured citrus microbiome, a
Pantoea isolate with high taxonomic identity to
Pantoea agglomerans and
Pantoea vagans was found to secrete compounds inhibitory to
L. crescens BT-1. Both of these
Pantoea species are prevalent in cultivated crop systems (
68–70) and have been used as biocontrol agents against plant diseases caused by bacteria, fungi, and oomycetes (
68,
71). These
Pantoea species have been developed into the commercial products, Bloomtime Biological FD biopesticide (Verdesian Life Sciences) and BlightBan C9-1 (Nufarm, Inc.), respectively.
P. vagans suppresses fire blight of pear and apple as a standalone treatment (
72). In contrast, in other studies,
P. vagans was found to be ineffective at controlling fire blight in apple as a standalone treatment but efficacious when combined with streptomycin applications, reducing the number of streptomycin applications necessary to effectively suppress fire blight (
73). Based on these results, our current and future research focuses include the isolation and identification of bioactive molecules produced by
E. nigrum,
Pantoea strains, and other microbes identified as inhibitory to
L. crescens via our experimentation pipeline.
The elucidation of antipathogen chemistries produced by phytobiome constituents provides a foundation for future experiments aimed at enriching disease suppression in a diseased plant environment. In the HLB pathosystem, efforts to harness biologicals or their bioactive metabolites for the management of HLB via direct application face significant challenges (
74). Among these is the fastidious nature of the pathogen “
Ca. Liberibacter asiaticus,” as it is localized to the phloem, a difficult-to-access sector of the plant endosphere. Moreover, “
Ca. Liberibacter asiaticus” is delivered directly to the phloem by its insect vector and has no known epiphytic phase. Thus, anti-“
Ca. Liberibacter asiaticus” applications based on direct activity against the pathogen will require entry to the phloem. The next steps of this collective work are to evaluate the cladosporols (and/or other to-be-isolated natural products) for anti-“
Ca. Liberibacter asiaticus” activity within citrus trees. Most importantly, assays designed to track the transit pathways of those molecules
in planta are necessary to assess bioavailability across tissue compartments. It will also be pertinent to determine whether the “
Ca. Liberibacter asiaticus”-inhibitory metabolites are produced by their respective microbes
in planta. Empirical assessment of the potential for these microbes to be used, either directly as bioinoculants, or through cultural practices enriching their abundance
in planta, to curtail “
Ca. Liberibacter asiaticus,” and thus mitigate HLB, are the next steps for this research. Our overall goal is to determine how the citrus phytobiome interfaces with the “
Ca. Liberibacter asiaticus” pathogen and eventually to understand the impact of microbial community composition on HLB outcomes. In the long term, these findings will lay the foundation for the development of sustainable plant disease mitigation strategies for commercial citriculture.